[Short-term study of proglumetacin].

Twenty-five patients with joint rheumatoid pain were treated as outpatients during 15 days with 450 mg/day fo proglumetacin. Efficacy was "good" or "very good" in 64% of the patients. No case of clinically significant side-effects was observed.